We are live on ! Find out more
CSBR icon

Champions Oncology
CSBR

37 hedge funds and large institutions have $100M invested in Champions Oncology in 2018 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

633% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 3

267% more capital invested

Capital invested by funds: $27.3M → $100M (+$72.7M)

167% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 3

106% more funds holding

Funds holding: 18 → 37 (+19)

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

12.36% more ownership

Funds ownership: 39.08% → 51.44% (+12%)

Holders
37
Holders Change
+19
Holders Change %
+105.56%
% of All Funds
0.85%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
22
Increased
8
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EI
EAM Investors
California
+$1.6M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.47M
3
ISL
Ingalls & Snyder LLC
New York
+$1.41M
4
SSA
Schonfeld Strategic Advisors
New York
+$1.11M
5
JP Morgan Chase
JP Morgan Chase
New York
+$1.1M

Top Sellers

Rank Fund Capital Flow
1
TAM
Tocqueville Asset Management
New York
-$226K
2
EIM
Essex Investment Management
Massachusetts
-$209K
3
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$76K
4
SSB
Sandy Spring Bank
Maryland
-$53K
5
TRCT
Tower Research Capital (TRC)
New York
-$11K
Name Holding Trade Value Shares
Change 		Change in
Stake
BPI
1
Battery Partners IX
Massachusetts
$34.1M – – –
NMC
2
NEA Management Company
Maryland
$27.3M – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$4.64M +$1.47M +165,246 +164%
Vanguard Group
4
Vanguard Group
Pennsylvania
$4.04M +$698K +78,428 +51%
PCM
5
Perkins Capital Management
Minnesota
$3.15M +$691K +77,600 +75%
EI
6
EAM Investors
California
$3.14M +$1.6M +179,973 New
ISL
7
Ingalls & Snyder LLC
New York
$2.77M +$1.41M +158,648 New
GIP
8
Granite Investment Partners
California
$2.44M – – –
SSA
9
Schonfeld Strategic Advisors
New York
$2.18M +$1.11M +125,000 New
JP Morgan Chase
10
JP Morgan Chase
New York
$2.16M +$1.1M +123,770 New
BlackRock
11
BlackRock
New York
$2.16M +$955K +107,202 +656%
EGI
12
EAM Global Investors
California
$1.85M +$943K +105,903 New
TAM
13
Tocqueville Asset Management
New York
$1.56M -$226K -25,383 -22%
EIM
14
Essex Investment Management
Massachusetts
$1.37M -$209K -23,523 -23%
Deutsche Bank
15
Deutsche Bank
Germany
$1.31M +$518K +58,147 +340%
Acadian Asset Management
16
Acadian Asset Management
Massachusetts
$1.25M +$637K +71,484 New
DCM
17
Driehaus Capital Management
Illinois
$660K +$475K +53,400 New
VF
18
Virtu Financial
New York
$642K +$327K +36,751 New
CAM
19
ClariVest Asset Management
California
$536K +$273K +30,700 New
Northern Trust
20
Northern Trust
Illinois
$449K +$229K +25,702 New
Millennium Management
21
Millennium Management
New York
$443K +$226K +25,369 New
Geode Capital Management
22
Geode Capital Management
Massachusetts
$424K +$216K +24,294 New
OC
23
Oppenheimer & Co
New York
$344K +$176K +19,715 New
Bank of Montreal
24
Bank of Montreal
Ontario, Canada
$250K +$127K +14,288 New
Arrowstreet Capital
25
Arrowstreet Capital
Massachusetts
$225K +$115K +12,906 New
1
2

CSBR Hedge Fund Activity: Q3 2018 in Review

37 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q3 2018, worth a combined $100M — up 267% from $27.3M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CSBR positions and 3 closed out — a net gain of 19 holders — while 8 added to existing stakes and 3 trimmed.

The largest buyer was EAM Investors, opening a new position worth an estimated $1.6M. The largest seller was Tocqueville Asset Management, cutting an estimated $226K.

  • 37 institutional investors held Champions Oncology (CSBR) as of Q3 2018, up from 18 in Q2 2018.
  • Funds reported $100M of Champions Oncology stock for Q3 2018, up 267% quarter-over-quarter.
  • 22 funds opened new Champions Oncology positions in Q3 2018 and 3 closed out, a net change of +19 holders.
  • The largest Champions Oncology buyer in Q3 2018 was EAM Investors, an estimated $1.6M added.
  • The largest Champions Oncology seller in Q3 2018 was Tocqueville Asset Management, an estimated $226K sold.

Based on aggregated 13F filings for Q3 2018.